Page 283 - Read Online

Page 14 of 15 Mohamedi et al. J Cancer Metastasis Treat 2019;5:37 I http://dx.doi.org/10.20517/2394-4722.2018.81

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Binder MJ, McCoombe S, Williams ED, McCulloch DR, Ward AC. The extracellular matrix in cancer progression: role of hyalectan
proteoglycans and ADAMTS enzymes. Cancer Lett 2017;385:55-64.
2. Tsuda T. Extracellular interactions between fibulins and transforming growth factor (TGF)-beta in physiological and pathological
conditions. Int J Mol Sci 2018;19:E2787.
3. Spaw M, Anant S, Thomas SM. Stromal contributions to the carcinogenic process. Mol Carcinog 2017;56:1199-213.
4. Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs)
family. Genome Biol 2015;16:113.
5. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, et al. Molecular cloning of a gene encoding a new type of metalloproteinase-
disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272:556-62.
6. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, et al. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth,
fertility, and organ morphology and function. J Clin Invest 2000;105:1345-52.
7. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci
2003;995:183-90.
8. Brown HM, Dunning KR, Robker RL, Boerboom D, Pritchard M, et al. ADAMTS1 cleavage of versican mediates essential structural
remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol Reprod 2010;83:549-57.
9. Tan Ide A, Ricciardelli C, Russell DL. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and
metastatic pathways. Int J Cancer 2013;133:2263-76.
10. Ricciardelli C, Frewin KM, tan Ide A, Williams ED, Opeskin K, et al. The ADAMTS1 protease gene is required for mammary tumor
growth and metastasis. Am J Pathol 2011;179:3075-85.
11. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively.
Oncogene 2006;25:2452-67.
12. Obika M, Ogawa H, Takahashi K, Li J, Hatipoglu OF, et al. Tumor growth inhibitory effect of ADAMTS1 is accompanied by the
inhibition of tumor angiogenesis. Cancer Sci 2012;103:1889-97.
13. Hirano T, Hirose K, Sakurai K, Makishima M, Sasaki K, et al. Inhibition of tumor growth by antibody to ADAMTS1 in mouse xenografts
of breast cancer. Anticancer Res 2011;31:3839-42.
14. Freitas VM, do Amaral JB, Silva TA, Santos ES, Mangone FR, et al. Decreased expression of ADAMTS-1 in human breast tumors
stimulates migration and invasion. Mol Cancer 2013;12:2.
15. Tyan SW, Hsu CH, Peng KL, Chen CC, Kuo WH, et al. Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer
invasion through an epigenetic change. PLoS One 2012;7:e35128.
16. Ham SA, Yoo T, Lee WJ, Hwang JS, Hur J, et al. ADAMTS1-mediated targeting of TSP-1 by PPARdelta suppresses migration and
invasion of breast cancer cells. Oncotarget 2017;8:94091-103.
17. Li M, Liu L, Zang W, Wang Y, Du Y, et al. miR365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in
breast cancer. Int J Oncol 2015;47:296-302.
18. Cal S, Lopez-Otin C. ADAMTS proteases and cancer. Matrix Biol 2015;44-46:77-85. [DOI: 10.1016/j.matbio.2015.01.013]
19. Lee NV, Rodriguez-Manzaneque JC, Thai SN, Twal WO, Luque A, et al. Fibulin-1 acts as a cofactor for the matrix metalloprotease
ADAMTS-1. J Biol Chem 2005;280:34796-804.
20. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E. Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit
cytoplasmic domain. Cell 1989;58:623-9.
21. de Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 2009;66:1890-902.
22. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002;115:2817-28.
23. Obaya AJ, Rua S, Moncada-Pazos A, Cal S. The dual role of fibulins in tumorigenesis. Cancer Lett 2012;325:132-8.
24. Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, et al. Elevated expression and altered processing of fibulin-1 protein in
human breast cancer. Br J Cancer 2003;88:871-8.
25. Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and
motility. J Cell Sci 2001;114:4587-98.
26. Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, et al. Suppression of anchorage-independent growth and matrigel invasion and
delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 1997;15:2159-68.
27. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003;4:479-
89.
28. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, et al. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer
cells. Oncogene 2002;21:1097-107.
29. Sadlonova A, Bowe DB, Novak Z, Mukherjee S, Duncan VE, et al. Identification of molecular distinctions between normal breast-
associated fibroblasts and breast cancer-associated fibroblasts. Cancer Microenviron 2009;2:9-21.